Monoethanolamine oleate
From Infogalactic: the planetary knowledge core
| File:Monoethanolammonium oleate.png | |
| Systematic (IUPAC) name | |
|---|---|
|
2-Hydroxyethylammonium oleate
|
|
| Clinical data | |
| AHFS/Drugs.com | Multum Consumer Information |
| Identifiers | |
| CAS Number | 2272-11-9  |
| ATC code | C05BB01 (WHO) |
| PubChem | CID: 5282489 |
| DrugBank | DB06689 |
| ChemSpider | 4445632 |
| UNII | U4RY8MRX7C |
| KEGG | D02276  |
| Chemical data | |
| Formula | C20H41NO3 |
| Molecular mass | 343.54444 g/mol |
| Physical data | |
| Density | 0.974 g/cm3 |
| (what is this?) (verify) |
|
Monoethanolamine oleate (properly ethanolammonium oleate) is an antivaricose agent. It is a salt formed by Lowry-Brønsted acid-base reaction between monoethanolamine and oleic acid, is systematically named 2-hydroxyethylammonium (9Z)-octadecenoate, and has a structural formula [CH3(CH2)7CH=CH(CH2)7CO2][H3NCH2CH2OH]. It is injected topically into varicosities to cause sclerosis (closure) of the abnormal vein.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
